Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1995 Mar 11;310(6980):627–631. doi: 10.1136/bmj.310.6980.627

Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease.

C M van Duijn 1, L M Havekes 1, C Van Broeckhoven 1, P de Knijff 1, A Hofman 1
PMCID: PMC2549007  PMID: 7703749

Abstract

OBJECTIVE--To investigate the hypothesis that differential survival between smokers and non-smokers leading to a decrease in the frequency of the e4 allele of the apolipoprotein E gene may explain the inverse relation between smoking history and early onset Alzheimer's disease. DESIGN--A population based case-control study. SETTING--The four northern provinces of the Netherlands and metropolitan Rotterdam. SUBJECTS--175 patients with early onset Alzheimer's disease and two independent control groups of 159 and 457 subjects. MAIN OUTCOME MEASURES--Frequencies of the apolipoprotein e4 allele and relative risk of early onset Alzheimer's disease. RESULTS--The inverse association between smoking history and early onset Alzheimer's disease could not be explained by a decrease in the frequency of the apolipoprotein e4 allele. Among carriers of this allele with a family history of dementia subjects with a history of smoking had a strongly reduced risk of early onset Alzheimer's disease (odds ratio 0.10 (95% confidence interval 0.01 to 0.87)). CONCLUSIONS--The results suggest that the inverse relation between smoking history and early onset Alzheimer's disease cannot be explained by an increased mortality in carriers of the apolipoprotein e4 allele who smoke. The association is strongly modified by the presence of the apolipoprotein e4 allele as well as by a family history of dementia.

Full text

PDF
627

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ben-Shlomo Y. Smoking and neurogenerative diseases. Lancet. 1993 Nov 13;342(8881):1239–1239. [PubMed] [Google Scholar]
  2. Benwell M. E., Balfour D. J., Anderson J. M. Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain. J Neurochem. 1988 Apr;50(4):1243–1247. doi: 10.1111/j.1471-4159.1988.tb10600.x. [DOI] [PubMed] [Google Scholar]
  3. Brenner D. E., Kukull W. A., van Belle G., Bowen J. D., McCormick W. C., Teri L., Larson E. B. Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology. 1993 Feb;43(2):293–300. doi: 10.1212/wnl.43.2.293. [DOI] [PubMed] [Google Scholar]
  4. Calne D. B., Langston J. W. Aetiology of Parkinson's disease. Lancet. 1983 Dec 24;2(8365-66):1457–1459. doi: 10.1016/s0140-6736(83)90802-4. [DOI] [PubMed] [Google Scholar]
  5. Chartier-Harlin M. C., Parfitt M., Legrain S., Pérez-Tur J., Brousseau T., Evans A., Berr C., Vidal O., Roques P., Gourlet V. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet. 1994 Apr;3(4):569–574. doi: 10.1093/hmg/3.4.569. [DOI] [PubMed] [Google Scholar]
  6. Davignon J., Gregg R. E., Sing C. F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988 Jan-Feb;8(1):1–21. doi: 10.1161/01.atv.8.1.1. [DOI] [PubMed] [Google Scholar]
  7. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  8. Graves A. B., van Duijn C. M., Chandra V., Fratiglioni L., Heyman A., Jorm A. F., Kokmen E., Kondo K., Mortimer J. A., Rocca W. A. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol. 1991;20 (Suppl 2):S48–S57. doi: 10.1093/ije/20.supplement_2.s48. [DOI] [PubMed] [Google Scholar]
  9. Hachinski V. C., Iliff L. D., Zilhka E., Du Boulay G. H., McAllister V. L., Marshall J., Russell R. W., Symon L. Cerebral blood flow in dementia. Arch Neurol. 1975 Sep;32(9):632–637. doi: 10.1001/archneur.1975.00490510088009. [DOI] [PubMed] [Google Scholar]
  10. Hardy J., Roberts G. W. Smoking and neurogenerative diseases. Lancet. 1993 Nov 13;342(8881):1238–1238. [PubMed] [Google Scholar]
  11. Hofman A., Schulte W., Tanja T. A., van Duijn C. M., Haaxma R., Lameris A. J., Otten V. M., Saan R. J. History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease. Neurology. 1989 Dec;39(12):1589–1592. doi: 10.1212/wnl.39.12.1589. [DOI] [PubMed] [Google Scholar]
  12. Larrick J. W., Wright S. C. Smoking and neurogenerative diseases. Lancet. 1993 Nov 13;342(8881):1238–1239. [PubMed] [Google Scholar]
  13. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  14. Morens D. M., Grandinetti A., Reed D., White L. R. Smoking-associated protection from Alzheimer's and Parkinson's disease. Lancet. 1994 Feb 5;343(8893):356–357. doi: 10.1016/s0140-6736(94)91194-0. [DOI] [PubMed] [Google Scholar]
  15. Riggs J. E. Smoking and Alzheimer's disease: protective effect or differential survival bias? Lancet. 1993 Sep 25;342(8874):793–794. doi: 10.1016/0140-6736(93)91547-y. [DOI] [PubMed] [Google Scholar]
  16. Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993 Aug;43(8):1467–1472. doi: 10.1212/wnl.43.8.1467. [DOI] [PubMed] [Google Scholar]
  17. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977–1981. doi: 10.1073/pnas.90.5.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L. M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., Roses A. D. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8098–8102. doi: 10.1073/pnas.90.17.8098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wenham P. R., Price W. H., Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991 May 11;337(8750):1158–1159. doi: 10.1016/0140-6736(91)92823-k. [DOI] [PubMed] [Google Scholar]
  20. van Duijn C. M., Hofman A. Relation between nicotine intake and Alzheimer's disease. BMJ. 1991 Jun 22;302(6791):1491–1494. doi: 10.1136/bmj.302.6791.1491. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES